Dry Needling and Exercise for Mid-portion Achilles Tendinopathy (DART)

June 10, 2026 updated by: Sean Boulanger, Brooke Army Medical Center

The Effect of Adding Ultrasound-guided Tendon Dry Needling to a Program of Heavy, Slow Loading Exercise for Individuals With Non-insertional Achilles Tendinopathy: A Single-blind Randomized Control Trial.

The purpose of this study is to determine if adding ultrasound-guided tendon dry needling with mechanical needle stimulation to a standard heavy, slow resistance (HSR) exercise program improves outcomes for individuals with chronic midportion Achilles tendinopathy. Achilles tendinopathy is a common condition causing long-term pain and reduced function in the main heel tendon.

All participants in this study will engage in a standardized 12-week physical therapy exercise program targeting the calf and Achilles tendon complex. Exercises are performed three times per week, combining supervised clinic sessions and home exercises, with the workload safely progressing over time based on individual performance and pain monitoring.

In addition to the standard exercise program, participants will be randomly assigned to one of two groups to evaluate the effect of the dry needling procedure. The experimental group will receive 6 sessions of ultrasound-guided tendon dry needling over approximately 6 weeks, where fine needles are inserted into the affected area of the tendon and gently rotated under ultrasound visualization to stimulate tissue remodeling. The control group will receive an identical schedule of "sham" (placebo) needling, using a toothpick device inside a needle sheath to mimic the sensation without actually penetrating the skin.

Improvements in pain, physical function, and physical performance (such as a heel-rise endurance test) will be recorded at baseline, 6 weeks, 12 weeks, and 26 weeks. Ultrasound imaging will also be used to evaluate structural changes inside the tendon, such as thickness and blood flow. The primary objective is to compare changes in Achilles-specific pain and function scores between the two groups at the conclusion of the 12-week intervention to determine if actual dry needling provides superior therapeutic benefits compared to exercise alone.

Study Overview

Status

Enrolling by invitation

Detailed Description

Purpose:

The purpose of this study is to determine whether adding ultrasound-guided tendon dry needling with mechanical needle stimulation to a standardized heavy, slow resistance (HSR) exercise program results in greater improvements in pain, function, and tendon structure compared to HSR exercise alone in individuals with chronic midportion (non-insertional) Achilles tendinopathy.

Subject Population:

The study will recruit 74 adult male and female Tricare beneficiaries aged 18-64 years from the Joint Base San Antonio (JBSA) area. Eligible participants must have non-acute (>6 weeks) midportion Achilles tendinopathy, defined as pain localized 2-7 cm proximal to the Achilles insertion that is provoked by loading activities such as walking, running, or jumping. Individuals with prior Achilles rupture or surgery, insertional Achilles pain only, systemic inflammatory or neurologic conditions, recent corticosteroid injections, needle phobia, pregnancy, trainee status, or other specified exclusion criteria will be excluded.

Study Design:

This study will be a single-blind superiority randomized control trial with two arms. Participants will be randomly assigned to one of two groups: (1) standard physical therapy combined with ultrasound-guided tendon dry needling, or (2) standard physical therapy with sham tendon needling. Participants will be blinded to group allocation, while the treating clinician cannot be blinded due to the nature of the intervention.

Procedures:

Following informed consent, participants will complete baseline assessments including demographic data, self-report questionnaires, ultrasound imaging of the Achilles tendon, and physical performance testing. Self-report outcomes include the Victorian Institute of Sport Assessment-Achilles (VISA-A), Patient Acceptable Symptom State (PASS), and Patient-Reported Outcomes Measurement Information System(PROMIS)-29. Physical testing includes the heel-rise test and standard physical therapy evaluation. Ultrasound measures will assess tendon thickness, neovascularization (Ohberg scale), and echogenicity.

All participants will receive standard physical therapy care, to include a standardized 12-week exercise program targeting the calf-Achilles complex and standardized manual therapy techniques as clinically indicated. Exercises will be performed three times per week, with one supervised session and two home sessions. Exercise load will progress over time and be guided by pain monitoring and performance. Compliance will be tracked using exercise logs.

Participants randomized to the experimental group will receive ultrasound-guided tendon dry needling in 6 sessions over approximately 6 weeks. Multiple filiform needles will be inserted into the pathological region of the tendon (identified by ultrasound or tenderness, if no signs are present) and mechanically stimulated via rotation under ultrasound guidance. Participants in the control group will receive sham needling using the same procedure and with the same schedule, instead using a toothpick housed in a needle sheath to simulate the procedure without tissue penetration.

Outcome measures will be collected at baseline, 6 weeks, and 12 weeks, with an additional survey-based follow-up at 26 weeks. The primary outcome is the between-group difference in VISA-A score at 12 weeks. Secondary outcomes include tendon structural changes, additional patient-reported outcomes, physical performance measures, and longer-term symptom acceptability.

Study Type

Interventional

Enrollment (Estimated)

74

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Fort Sam Houston, Texas, United States, 78324
        • CPT Jennifer Moreno Primary Care Clinic - Physical Therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Symptoms in one or both Achilles tendons
  • Pain reported in Achilles with running, jumping or walking
  • Symtom duration ≥ 6 weeks
  • Age 18-64
  • English-speaking

Exclusion Criteria:

  • Score > 80 on VISA-A
  • Prior Achilles rupture or surgery
  • Pain reported in Achilles insertion to calcaneus only
  • Needle phobia
  • Self-reported pregnancy
  • Trainee status
  • Corticosteroid injection in the past 3 months into the Achilles tendon
  • Unable to participate in 12 week program
  • Taken Quinolone antibiotics past three months (e.g. Cipro, Levaquin, Floxin, Baxdela)
  • Currently undergoing separation from the military
  • Diagnosis of rheumatoid arthritis, systemic connective tissue disorder, or neurological disorder affecting the lower leg.
  • Symptoms in Achilles tendon are from another source (e.g. S1 radicular pain, referred pain, sural nerve entrapment)
  • Currently undergoing active physical therapy elsewhere for Achilles pain

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dry Needling Group
This group will undergo a standardized calf strengthening program in addition to receiving tendon dry needling under ultrasound guidance once a week for 6 weeks. Needling will include up to 5 needle passes into every centimeter of the tender or tendinopathic area (if visible on ultrasound) at varying angles with at minimum two needles placed while under ultrasound guidance. The ultrasound unit will be placed in long axis to the Achilles tendon on the opposite side of the needling with an in-plane view and needle direction of 45 degrees caudally. The needles will then be rotated unilaterally until resistance is felt by the clinician or if the symptoms reach the upper limit of the participant's tolerance. This will be repeated as tolerated no less than twice in a 10-minute period, then the needles will be removed. The remainder of the session will be spent performing exercise or manual therapy as deemed necessary by the treating clinician.
Dry needling is the use of filiform needles without injectate. The needles are 0.30mm wide and far smaller than typical needles used for injection. Needle fenestration is performed and followed by needle rotation in this study.
Sham Comparator: Sham Needling Group
This group will undergo a standardized calf strengthening program in addition to receiving sham dry needling once a week for 6 weeks. The same procedures will be used as the experimental group, with ultrasound imaging applied longitudinally opposite to the sham needling, but using a toothpick to simulate a needle. The toothpick will be applied to the skin through a needle tube and rotated for 15-30 seconds. This will be applied for every one centimeter of tender or tendinopathic tendon and repeated until ten minutes has elapsed. The remainder of the session will be spent performing exercise or manual therapy as deemed necessary by the treating clinician.
This will be used as described by Hando et al 2025, using a toothpick to simulate a needle puncture.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Victorian Institute of Sport Assessment - Achilles
Time Frame: From enrollment to 12 weeks
The Victorian Institute of Sport Assessment - Achilles (VISA-A) is a questionnaire that is validated to measure pain, function and activity for people affected by Achilles tendon pain. It is rated 0-100, with increasing function at higher scores.
From enrollment to 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Acceptable Symptomatic State (PASS)
Time Frame: Enrollment, 6, 12 and 26 weeks
A binary yes or no question asking if symptoms are acceptable to the individual.
Enrollment, 6, 12 and 26 weeks
Healthcare Utilization
Time Frame: Enrollment, 6-, 12- and 26-weeks
Participants will be queried on the healthcare resources they have used up to the time of taking this questionnaire. Items include other interventions, medication use, and specialty referrals.
Enrollment, 6-, 12- and 26-weeks
Ultrasound Measurements
Time Frame: Enrollment and 12-weeks
Ultrasound images of the tendon will be taken, including thickness measurements, Doppler grading, and echogenicity (brightness) rating. Thickness will be measured in the anterior-posterior element in the transverse plane, measured three times and averaged at the thickest visible part of the tendon. Doppler imaging will be taken to determine the number of blood vessels present in the tendon using the Ohberg scale (rated 0-4 in increasing vascularity). Lastly, the Continuum Model of tendinopathy will be used to grade the tendon echogenicity from 0-2, with a higher score indicating less compact and darker structure compared to healthy tendon.
Enrollment and 12-weeks
Heel rise test
Time Frame: This test will be performed at baseline, 6- and 12-week follow-ups.
The heel rise test is a muscular performance test. The participant is asked to perform as many heel rises as possible on one foot at a rate of 30 repetitions per minute with full range of motion. The test is discontinued if the participant cannot complete any more repetitions with full range of motion or if pain exceeds tolerable levels. For the purposes of this study, a verbal pain scale score of greater than 5/10 will be utilized.
This test will be performed at baseline, 6- and 12-week follow-ups.
Patient-Reported Outcomes Measurement Information System - 29 (PROMIS-29)
Time Frame: Enrollment, 6-, 12- and 26-weeks
A comprehensive health questionnaire that covers the domains of physical function, anxiety, depression, fatigue, sleep disturbance, social participation, pain interference and pain intensity. Items are rated from 1 to 5 on a Likert scale and scores are converted into a standardized T-score (mean of 50, standard deviation of 10). The score is adjusted by age and gender.
Enrollment, 6-, 12- and 26-weeks
Victorian Institute of Sports Assessment - Achilles
Time Frame: In addition to enrollment and 12-weeks (primary outcome), 6- and 26-week measures will be used as secondary outcomes.
The Victorian Institute of Sport Assessment - Achilles (VISA-A) is a questionnaire that is validated to measure pain, function and activity for people affected by Achilles tendon pain. It is rated 0-100, with increasing function at higher scores.
In addition to enrollment and 12-weeks (primary outcome), 6- and 26-week measures will be used as secondary outcomes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Benjamin Hando, DSc, PhD, Army-Baylor Doctoral Fellowship in Orthopedic Manual Physical Therapy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 2, 2026

Primary Completion (Estimated)

March 30, 2027

Study Completion (Estimated)

July 7, 2027

Study Registration Dates

First Submitted

June 8, 2026

First Submitted That Met QC Criteria

June 8, 2026

First Posted (Actual)

June 11, 2026

Study Record Updates

Last Update Posted (Actual)

June 12, 2026

Last Update Submitted That Met QC Criteria

June 10, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Non-Insertional Achilles Tendinopathy

Clinical Trials on Dry needling

Subscribe